nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—MTNR1A—type 2 diabetes mellitus	0.311	0.568	CbGaD
Agomelatine—MTNR1B—type 2 diabetes mellitus	0.163	0.298	CbGaD
Agomelatine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0485	0.166	CbGbCtD
Agomelatine—HTR2C—type 2 diabetes mellitus	0.0417	0.0762	CbGaD
Agomelatine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0315	0.108	CbGbCtD
Agomelatine—CYP1A2—type 2 diabetes mellitus	0.0314	0.0575	CbGaD
Agomelatine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0208	0.0715	CbGbCtD
Agomelatine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.019	0.0654	CbGbCtD
Agomelatine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0177	0.0608	CbGbCtD
Agomelatine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0154	0.053	CbGbCtD
Agomelatine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0151	0.0517	CbGbCtD
Agomelatine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0151	0.0517	CbGbCtD
Agomelatine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0139	0.0477	CbGbCtD
Agomelatine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0134	0.0461	CbGbCtD
Agomelatine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0123	0.0422	CbGbCtD
Agomelatine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0121	0.0417	CbGbCtD
Agomelatine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0115	0.0394	CbGbCtD
Agomelatine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0114	0.0392	CbGbCtD
Agomelatine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0109	0.0376	CbGbCtD
Agomelatine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00782	0.0269	CbGbCtD
Agomelatine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00771	0.0265	CbGbCtD
Agomelatine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00705	0.0242	CbGbCtD
Agomelatine—Melatonin—MTNR1A—type 2 diabetes mellitus	0.000955	0.299	CrCbGaD
Agomelatine—Melatonin—MTNR1B—type 2 diabetes mellitus	0.000502	0.157	CrCbGaD
Agomelatine—Melatonin—CALM1—type 2 diabetes mellitus	0.000307	0.0964	CrCbGaD
Agomelatine—Indomethacin—PPARA—type 2 diabetes mellitus	0.000292	0.0914	CrCbGaD
Agomelatine—Nabumetone—CYP1A2—type 2 diabetes mellitus	0.000243	0.0761	CrCbGaD
Agomelatine—Nabumetone—PTGS2—type 2 diabetes mellitus	0.000157	0.0493	CrCbGaD
Agomelatine—Back pain—Valsartan—type 2 diabetes mellitus	0.000154	0.00159	CcSEcCtD
Agomelatine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000153	0.00158	CcSEcCtD
Agomelatine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000152	0.00157	CcSEcCtD
Agomelatine—Back pain—Orlistat—type 2 diabetes mellitus	0.000152	0.00157	CcSEcCtD
Agomelatine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000152	0.00156	CcSEcCtD
Agomelatine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000152	0.00156	CcSEcCtD
Agomelatine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000151	0.00156	CcSEcCtD
Agomelatine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000151	0.00155	CcSEcCtD
Agomelatine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00015	0.00155	CcSEcCtD
Agomelatine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00015	0.00154	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000149	0.00153	CcSEcCtD
Agomelatine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000148	0.00153	CcSEcCtD
Agomelatine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000148	0.00153	CcSEcCtD
Agomelatine—Hepatitis—Losartan—type 2 diabetes mellitus	0.000148	0.00152	CcSEcCtD
Agomelatine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000147	0.00152	CcSEcCtD
Agomelatine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000147	0.00151	CcSEcCtD
Agomelatine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000147	0.00151	CcSEcCtD
Agomelatine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000147	0.00151	CcSEcCtD
Agomelatine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000146	0.00151	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000146	0.00151	CcSEcCtD
Agomelatine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000146	0.00151	CcSEcCtD
Agomelatine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000145	0.0015	CcSEcCtD
Agomelatine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000145	0.00149	CcSEcCtD
Agomelatine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000144	0.00149	CcSEcCtD
Agomelatine—Weight increased—Ramipril—type 2 diabetes mellitus	0.000144	0.00148	CcSEcCtD
Agomelatine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000144	0.00148	CcSEcCtD
Agomelatine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000143	0.00147	CcSEcCtD
Agomelatine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000141	0.00146	CcSEcCtD
Agomelatine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000141	0.00145	CcSEcCtD
Agomelatine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00145	CcSEcCtD
Agomelatine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000141	0.00145	CcSEcCtD
Agomelatine—Infection—Gliclazide—type 2 diabetes mellitus	0.00014	0.00145	CcSEcCtD
Agomelatine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00014	0.00144	CcSEcCtD
Agomelatine—Indomethacin—PPARG—type 2 diabetes mellitus	0.00014	0.0438	CrCbGaD
Agomelatine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000139	0.00143	CcSEcCtD
Agomelatine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000139	0.00143	CcSEcCtD
Agomelatine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000139	0.00143	CcSEcCtD
Agomelatine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000138	0.00142	CcSEcCtD
Agomelatine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000138	0.00142	CcSEcCtD
Agomelatine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000137	0.00141	CcSEcCtD
Agomelatine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000137	0.00141	CcSEcCtD
Agomelatine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000137	0.00141	CcSEcCtD
Agomelatine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000137	0.00141	CcSEcCtD
Agomelatine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000137	0.00141	CcSEcCtD
Agomelatine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000136	0.00141	CcSEcCtD
Agomelatine—Indomethacin—ABCC2—type 2 diabetes mellitus	0.000136	0.0427	CrCbGaD
Agomelatine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000136	0.0014	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000136	0.0014	CcSEcCtD
Agomelatine—Tremor—Metformin—type 2 diabetes mellitus	0.000136	0.0014	CcSEcCtD
Agomelatine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000135	0.00139	CcSEcCtD
Agomelatine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000135	0.00139	CcSEcCtD
Agomelatine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000135	0.00139	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000134	0.00139	CcSEcCtD
Agomelatine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000134	0.00138	CcSEcCtD
Agomelatine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000133	0.00138	CcSEcCtD
Agomelatine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000133	0.00137	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000133	0.00137	CcSEcCtD
Agomelatine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000132	0.00136	CcSEcCtD
Agomelatine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000131	0.00135	CcSEcCtD
Agomelatine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000131	0.00134	CcSEcCtD
Agomelatine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00013	0.00134	CcSEcCtD
Agomelatine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00013	0.00134	CcSEcCtD
Agomelatine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00013	0.00133	CcSEcCtD
Agomelatine—Infection—Valsartan—type 2 diabetes mellitus	0.000129	0.00133	CcSEcCtD
Agomelatine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000129	0.00133	CcSEcCtD
Agomelatine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000129	0.00133	CcSEcCtD
Agomelatine—Headache—Glipizide—type 2 diabetes mellitus	0.000128	0.00132	CcSEcCtD
Agomelatine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000128	0.00132	CcSEcCtD
Agomelatine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000128	0.00132	CcSEcCtD
Agomelatine—Infection—Orlistat—type 2 diabetes mellitus	0.000127	0.00131	CcSEcCtD
Agomelatine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000127	0.00131	CcSEcCtD
Agomelatine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000127	0.00131	CcSEcCtD
Agomelatine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000127	0.00131	CcSEcCtD
Agomelatine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000126	0.0013	CcSEcCtD
Agomelatine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000126	0.0013	CcSEcCtD
Agomelatine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000126	0.0013	CcSEcCtD
Agomelatine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000126	0.0013	CcSEcCtD
Agomelatine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000126	0.00129	CcSEcCtD
Agomelatine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000126	0.00129	CcSEcCtD
Agomelatine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000125	0.00129	CcSEcCtD
Agomelatine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000125	0.00129	CcSEcCtD
Agomelatine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000125	0.00128	CcSEcCtD
Agomelatine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000125	0.00128	CcSEcCtD
Agomelatine—Back pain—Losartan—type 2 diabetes mellitus	0.000124	0.00128	CcSEcCtD
Agomelatine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000124	0.00128	CcSEcCtD
Agomelatine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000124	0.00128	CcSEcCtD
Agomelatine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000124	0.00128	CcSEcCtD
Agomelatine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000123	0.00127	CcSEcCtD
Agomelatine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000123	0.00127	CcSEcCtD
Agomelatine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000123	0.00126	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000122	0.00126	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000122	0.00126	CcSEcCtD
Agomelatine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000122	0.00126	CcSEcCtD
Agomelatine—Nausea—Glipizide—type 2 diabetes mellitus	0.000121	0.00125	CcSEcCtD
Agomelatine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000121	0.00125	CcSEcCtD
Agomelatine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000121	0.00125	CcSEcCtD
Agomelatine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000121	0.00125	CcSEcCtD
Agomelatine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000121	0.00124	CcSEcCtD
Agomelatine—Tremor—Losartan—type 2 diabetes mellitus	0.000121	0.00124	CcSEcCtD
Agomelatine—Headache—Glimepiride—type 2 diabetes mellitus	0.00012	0.00123	CcSEcCtD
Agomelatine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000119	0.00123	CcSEcCtD
Agomelatine—Agitation—Losartan—type 2 diabetes mellitus	0.000118	0.00122	CcSEcCtD
Agomelatine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000118	0.00122	CcSEcCtD
Agomelatine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Agomelatine—Angioedema—Losartan—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Agomelatine—Infection—Metformin—type 2 diabetes mellitus	0.000117	0.00121	CcSEcCtD
Agomelatine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000117	0.00121	CcSEcCtD
Agomelatine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000117	0.0012	CcSEcCtD
Agomelatine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000116	0.0012	CcSEcCtD
Agomelatine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Agomelatine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Agomelatine—Vertigo—Losartan—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Agomelatine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Agomelatine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000115	0.00119	CcSEcCtD
Agomelatine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000115	0.00119	CcSEcCtD
Agomelatine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000115	0.00118	CcSEcCtD
Agomelatine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000114	0.00118	CcSEcCtD
Agomelatine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000114	0.00118	CcSEcCtD
Agomelatine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Agomelatine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Agomelatine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000113	0.00117	CcSEcCtD
Agomelatine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Agomelatine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Agomelatine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Agomelatine—Naproxen—CYP1A2—type 2 diabetes mellitus	0.000112	0.0352	CrCbGaD
Agomelatine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000112	0.00116	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Agomelatine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Agomelatine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Agomelatine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000111	0.00115	CcSEcCtD
Agomelatine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Agomelatine—Constipation—Valsartan—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Agomelatine—Infection—Irbesartan—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Agomelatine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Agomelatine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000109	0.00113	CcSEcCtD
Agomelatine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000109	0.00113	CcSEcCtD
Agomelatine—Anxiety—Losartan—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Agomelatine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000108	0.00112	CcSEcCtD
Agomelatine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Agomelatine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Agomelatine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Agomelatine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000107	0.0011	CcSEcCtD
Agomelatine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Agomelatine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Agomelatine—Somnolence—Metformin—type 2 diabetes mellitus	0.000105	0.00108	CcSEcCtD
Agomelatine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000105	0.00108	CcSEcCtD
Agomelatine—Infection—Losartan—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Agomelatine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Agomelatine—Tremor—Ramipril—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Agomelatine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Agomelatine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Agomelatine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Agomelatine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Agomelatine—Fatigue—Metformin—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Agomelatine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Agomelatine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000101	0.00105	CcSEcCtD
Agomelatine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Agomelatine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Agomelatine—Agitation—Ramipril—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Agomelatine—Constipation—Metformin—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Agomelatine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Agomelatine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.0001	0.00103	CcSEcCtD
Agomelatine—Vomiting—Glyburide—type 2 diabetes mellitus	0.0001	0.00103	CcSEcCtD
Agomelatine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.0001	0.00103	CcSEcCtD
Agomelatine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.92e-05	0.00102	CcSEcCtD
Agomelatine—Vertigo—Ramipril—type 2 diabetes mellitus	9.91e-05	0.00102	CcSEcCtD
Agomelatine—Headache—Glyburide—type 2 diabetes mellitus	9.86e-05	0.00102	CcSEcCtD
Agomelatine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.82e-05	0.00101	CcSEcCtD
Agomelatine—Melatonin—CYP1A2—type 2 diabetes mellitus	9.67e-05	0.0303	CrCbGaD
Agomelatine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.67e-05	0.000996	CcSEcCtD
Agomelatine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.67e-05	0.000996	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000992	CcSEcCtD
Agomelatine—Fatigue—Irbesartan—type 2 diabetes mellitus	9.62e-05	0.000991	CcSEcCtD
Agomelatine—Constipation—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.000983	CcSEcCtD
Agomelatine—Insomnia—Losartan—type 2 diabetes mellitus	9.5e-05	0.000978	CcSEcCtD
Agomelatine—Paraesthesia—Losartan—type 2 diabetes mellitus	9.43e-05	0.000971	CcSEcCtD
Agomelatine—Urticaria—Metformin—type 2 diabetes mellitus	9.39e-05	0.000968	CcSEcCtD
Agomelatine—Anxiety—Ramipril—type 2 diabetes mellitus	9.36e-05	0.000964	CcSEcCtD
Agomelatine—Nausea—Glyburide—type 2 diabetes mellitus	9.35e-05	0.000963	CcSEcCtD
Agomelatine—Abdominal pain—Metformin—type 2 diabetes mellitus	9.34e-05	0.000963	CcSEcCtD
Agomelatine—Dizziness—Gliclazide—type 2 diabetes mellitus	9.34e-05	0.000963	CcSEcCtD
Agomelatine—Somnolence—Losartan—type 2 diabetes mellitus	9.33e-05	0.000962	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.33e-05	0.000961	CcSEcCtD
Agomelatine—Asthenia—Valsartan—type 2 diabetes mellitus	9.31e-05	0.00096	CcSEcCtD
Agomelatine—Dyspepsia—Losartan—type 2 diabetes mellitus	9.24e-05	0.000952	CcSEcCtD
Agomelatine—Asthenia—Orlistat—type 2 diabetes mellitus	9.2e-05	0.000948	CcSEcCtD
Agomelatine—Pruritus—Valsartan—type 2 diabetes mellitus	9.18e-05	0.000946	CcSEcCtD
Agomelatine—Dry mouth—Ramipril—type 2 diabetes mellitus	9.18e-05	0.000946	CcSEcCtD
Agomelatine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.12e-05	0.00094	CcSEcCtD
Agomelatine—Pruritus—Orlistat—type 2 diabetes mellitus	9.07e-05	0.000935	CcSEcCtD
Agomelatine—Fatigue—Losartan—type 2 diabetes mellitus	9.05e-05	0.000933	CcSEcCtD
Agomelatine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.98e-05	0.000926	CcSEcCtD
Agomelatine—Constipation—Losartan—type 2 diabetes mellitus	8.98e-05	0.000925	CcSEcCtD
Agomelatine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.88e-05	0.000915	CcSEcCtD
Agomelatine—Urticaria—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.000913	CcSEcCtD
Agomelatine—Headache—Gliclazide—type 2 diabetes mellitus	8.85e-05	0.000912	CcSEcCtD
Agomelatine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.83e-05	0.00091	CcSEcCtD
Agomelatine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.82e-05	0.000909	CcSEcCtD
Agomelatine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.78e-05	0.000904	CcSEcCtD
Agomelatine—Skin disorder—Ramipril—type 2 diabetes mellitus	8.74e-05	0.000901	CcSEcCtD
Agomelatine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.7e-05	0.000897	CcSEcCtD
Agomelatine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.58e-05	0.000884	CcSEcCtD
Agomelatine—Dizziness—Valsartan—type 2 diabetes mellitus	8.58e-05	0.000884	CcSEcCtD
Agomelatine—Dizziness—Orlistat—type 2 diabetes mellitus	8.48e-05	0.000874	CcSEcCtD
Agomelatine—Asthenia—Metformin—type 2 diabetes mellitus	8.48e-05	0.000874	CcSEcCtD
Agomelatine—Nausea—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.000865	CcSEcCtD
Agomelatine—Pruritus—Metformin—type 2 diabetes mellitus	8.36e-05	0.000862	CcSEcCtD
Agomelatine—Urticaria—Losartan—type 2 diabetes mellitus	8.34e-05	0.000859	CcSEcCtD
Agomelatine—Abdominal pain—Losartan—type 2 diabetes mellitus	8.3e-05	0.000855	CcSEcCtD
Agomelatine—Vomiting—Valsartan—type 2 diabetes mellitus	8.25e-05	0.00085	CcSEcCtD
Agomelatine—Vomiting—Orlistat—type 2 diabetes mellitus	8.16e-05	0.00084	CcSEcCtD
Agomelatine—Insomnia—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000839	CcSEcCtD
Agomelatine—Headache—Valsartan—type 2 diabetes mellitus	8.13e-05	0.000838	CcSEcCtD
Agomelatine—Diarrhoea—Metformin—type 2 diabetes mellitus	8.09e-05	0.000833	CcSEcCtD
Agomelatine—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000833	CcSEcCtD
Agomelatine—Headache—Orlistat—type 2 diabetes mellitus	8.04e-05	0.000828	CcSEcCtD
Agomelatine—Asthenia—Irbesartan—type 2 diabetes mellitus	8e-05	0.000825	CcSEcCtD
Agomelatine—Somnolence—Ramipril—type 2 diabetes mellitus	8e-05	0.000825	CcSEcCtD
Agomelatine—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000816	CcSEcCtD
Agomelatine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000813	CcSEcCtD
Agomelatine—Dizziness—Metformin—type 2 diabetes mellitus	7.82e-05	0.000805	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000801	CcSEcCtD
Agomelatine—Fatigue—Ramipril—type 2 diabetes mellitus	7.76e-05	0.0008	CcSEcCtD
Agomelatine—Nausea—Valsartan—type 2 diabetes mellitus	7.71e-05	0.000794	CcSEcCtD
Agomelatine—Constipation—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000793	CcSEcCtD
Agomelatine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.000786	CcSEcCtD
Agomelatine—Nausea—Orlistat—type 2 diabetes mellitus	7.62e-05	0.000785	CcSEcCtD
Agomelatine—Asthenia—Losartan—type 2 diabetes mellitus	7.53e-05	0.000776	CcSEcCtD
Agomelatine—Vomiting—Metformin—type 2 diabetes mellitus	7.52e-05	0.000774	CcSEcCtD
Agomelatine—Pruritus—Losartan—type 2 diabetes mellitus	7.43e-05	0.000765	CcSEcCtD
Agomelatine—Headache—Metformin—type 2 diabetes mellitus	7.41e-05	0.000763	CcSEcCtD
Agomelatine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.00076	CcSEcCtD
Agomelatine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000758	CcSEcCtD
Agomelatine—Naproxen—PTGS2—type 2 diabetes mellitus	7.28e-05	0.0228	CrCbGaD
Agomelatine—Diarrhoea—Losartan—type 2 diabetes mellitus	7.18e-05	0.00074	CcSEcCtD
Agomelatine—Urticaria—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000737	CcSEcCtD
Agomelatine—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000733	CcSEcCtD
Agomelatine—Vomiting—Irbesartan—type 2 diabetes mellitus	7.09e-05	0.000731	CcSEcCtD
Agomelatine—Nausea—Metformin—type 2 diabetes mellitus	7.02e-05	0.000723	CcSEcCtD
Agomelatine—Headache—Irbesartan—type 2 diabetes mellitus	6.99e-05	0.00072	CcSEcCtD
Agomelatine—Dizziness—Losartan—type 2 diabetes mellitus	6.94e-05	0.000715	CcSEcCtD
Agomelatine—Vomiting—Losartan—type 2 diabetes mellitus	6.68e-05	0.000688	CcSEcCtD
Agomelatine—Nausea—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000683	CcSEcCtD
Agomelatine—Headache—Losartan—type 2 diabetes mellitus	6.58e-05	0.000678	CcSEcCtD
Agomelatine—Naproxen—ALB—type 2 diabetes mellitus	6.49e-05	0.0203	CrCbGaD
Agomelatine—Asthenia—Ramipril—type 2 diabetes mellitus	6.46e-05	0.000665	CcSEcCtD
Agomelatine—Pruritus—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000656	CcSEcCtD
Agomelatine—Nausea—Losartan—type 2 diabetes mellitus	6.24e-05	0.000642	CcSEcCtD
Agomelatine—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000635	CcSEcCtD
Agomelatine—Dizziness—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000613	CcSEcCtD
Agomelatine—Indomethacin—PTGS2—type 2 diabetes mellitus	5.9e-05	0.0185	CrCbGaD
Agomelatine—Vomiting—Ramipril—type 2 diabetes mellitus	5.72e-05	0.00059	CcSEcCtD
Agomelatine—Headache—Ramipril—type 2 diabetes mellitus	5.64e-05	0.000581	CcSEcCtD
Agomelatine—Nausea—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000551	CcSEcCtD
Agomelatine—Indomethacin—ALB—type 2 diabetes mellitus	5.26e-05	0.0165	CrCbGaD
Agomelatine—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	6.39e-06	0.000103	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	6.39e-06	0.000103	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	6.39e-06	0.000103	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.3e-06	0.000102	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.27e-06	0.000102	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.27e-06	0.000102	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	6.26e-06	0.000101	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.19e-06	0.0001	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.18e-06	0.0001	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.17e-06	9.99e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.13e-06	9.92e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	6.12e-06	9.92e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	6.12e-06	9.92e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.04e-06	9.79e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AVP—type 2 diabetes mellitus	6.04e-06	9.79e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	6.02e-06	9.75e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.02e-06	9.74e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.02e-06	9.74e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.99e-06	9.7e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.93e-06	9.6e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	5.9e-06	9.55e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	5.9e-06	9.55e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	5.87e-06	9.5e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.86e-06	9.49e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOB—type 2 diabetes mellitus	5.84e-06	9.46e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.83e-06	9.45e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.82e-06	9.42e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.81e-06	9.4e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	5.79e-06	9.38e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	5.79e-06	9.37e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.75e-06	9.31e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.74e-06	9.29e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GCG—type 2 diabetes mellitus	5.74e-06	9.29e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	5.69e-06	9.22e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	5.69e-06	9.22e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	5.69e-06	9.22e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	5.67e-06	9.17e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	5.67e-06	9.17e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	5.67e-06	9.17e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	5.67e-06	9.17e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.64e-06	9.14e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.62e-06	9.11e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LPL—type 2 diabetes mellitus	5.58e-06	9.03e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	5.52e-06	8.94e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.46e-06	8.84e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.45e-06	8.82e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	5.43e-06	8.8e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.41e-06	8.76e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.41e-06	8.76e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.37e-06	8.69e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	5.35e-06	8.67e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.28e-06	8.54e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.27e-06	8.54e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	5.27e-06	8.53e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.27e-06	8.53e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.23e-06	8.48e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.17e-06	8.37e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	5.14e-06	8.33e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.14e-06	8.32e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.11e-06	8.28e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	5.05e-06	8.18e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—C3—type 2 diabetes mellitus	5.02e-06	8.13e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	5.01e-06	8.12e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.01e-06	8.11e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.99e-06	8.08e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.99e-06	8.08e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.99e-06	8.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.94e-06	8e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AVP—type 2 diabetes mellitus	4.88e-06	7.9e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.88e-06	7.9e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.85e-06	7.86e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	4.84e-06	7.84e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	4.84e-06	7.84e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	4.84e-06	7.84e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	4.84e-06	7.84e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.83e-06	7.83e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.79e-06	7.76e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.78e-06	7.75e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.78e-06	7.74e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGT—type 2 diabetes mellitus	4.77e-06	7.73e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	4.71e-06	7.63e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOB—type 2 diabetes mellitus	4.71e-06	7.63e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.69e-06	7.6e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.69e-06	7.6e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LEP—type 2 diabetes mellitus	4.68e-06	7.57e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—type 2 diabetes mellitus	4.68e-06	7.57e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	4.66e-06	7.54e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	4.64e-06	7.52e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.64e-06	7.51e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.62e-06	7.48e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	4.62e-06	7.48e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	4.62e-06	7.48e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	4.53e-06	7.33e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	4.51e-06	7.3e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.5e-06	7.29e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	4.5e-06	7.29e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	4.5e-06	7.29e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	4.5e-06	7.29e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LPL—type 2 diabetes mellitus	4.5e-06	7.29e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	4.47e-06	7.24e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.42e-06	7.15e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.41e-06	7.14e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.41e-06	7.13e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	4.39e-06	7.11e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.37e-06	7.07e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.34e-06	7.03e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	4.32e-06	6.99e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.22e-06	6.84e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.17e-06	6.75e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.15e-06	6.71e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—C3—type 2 diabetes mellitus	4.05e-06	6.56e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.05e-06	6.56e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.04e-06	6.54e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.04e-06	6.54e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.04e-06	6.54e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.03e-06	6.52e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—INS—type 2 diabetes mellitus	3.99e-06	6.47e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.96e-06	6.42e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	3.95e-06	6.39e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	3.95e-06	6.39e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.93e-06	6.36e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.93e-06	6.36e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.87e-06	6.27e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.87e-06	6.27e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.86e-06	6.26e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.86e-06	6.26e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.86e-06	6.25e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.85e-06	6.24e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGT—type 2 diabetes mellitus	3.85e-06	6.23e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.85e-06	6.23e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.85e-06	6.23e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.85e-06	6.23e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.85e-06	6.23e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.84e-06	6.23e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.84e-06	6.22e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.82e-06	6.19e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.79e-06	6.13e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	3.77e-06	6.11e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	3.77e-06	6.11e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.75e-06	6.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.73e-06	6.04e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.71e-06	6.01e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.69e-06	5.98e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.67e-06	5.94e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.65e-06	5.91e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.65e-06	5.91e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.56e-06	5.77e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.56e-06	5.76e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.54e-06	5.74e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.5e-06	5.67e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.5e-06	5.67e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.5e-06	5.67e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.5e-06	5.67e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.46e-06	5.6e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.45e-06	5.59e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.45e-06	5.59e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.45e-06	5.59e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.39e-06	5.48e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.37e-06	5.45e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.36e-06	5.43e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.31e-06	5.36e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RELA—type 2 diabetes mellitus	3.3e-06	5.34e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.28e-06	5.32e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	3.22e-06	5.22e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.17e-06	5.13e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.16e-06	5.11e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.12e-06	5.05e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.12e-06	5.05e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.11e-06	5.04e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.1e-06	5.02e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.04e-06	4.93e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.03e-06	4.9e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.02e-06	4.89e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.02e-06	4.89e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3e-06	4.86e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3e-06	4.86e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.99e-06	4.84e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.99e-06	4.84e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.97e-06	4.82e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.96e-06	4.8e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.96e-06	4.79e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.95e-06	4.78e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.88e-06	4.66e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.83e-06	4.58e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.83e-06	4.58e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.81e-06	4.55e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.8e-06	4.53e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.78e-06	4.5e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.75e-06	4.45e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.73e-06	4.41e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.69e-06	4.35e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.68e-06	4.34e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	2.66e-06	4.31e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.61e-06	4.23e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.59e-06	4.2e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.58e-06	4.17e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.58e-06	4.17e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.58e-06	4.17e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.57e-06	4.16e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.53e-06	4.1e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.52e-06	4.09e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.47e-06	4e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.46e-06	3.98e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.43e-06	3.93e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.42e-06	3.92e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.4e-06	3.89e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.39e-06	3.87e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.38e-06	3.86e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.35e-06	3.81e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.35e-06	3.8e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.32e-06	3.75e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.31e-06	3.74e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.3e-06	3.73e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.3e-06	3.72e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.29e-06	3.71e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.28e-06	3.69e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.27e-06	3.68e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.27e-06	3.67e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.24e-06	3.63e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.23e-06	3.61e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.2e-06	3.57e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.2e-06	3.56e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.11e-06	3.42e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.09e-06	3.39e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.07e-06	3.36e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.04e-06	3.3e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.01e-06	3.25e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.01e-06	3.25e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.97e-06	3.2e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.97e-06	3.19e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.97e-06	3.19e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.94e-06	3.15e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.87e-06	3.03e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.83e-06	2.97e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.8e-06	2.92e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.75e-06	2.83e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.72e-06	2.79e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.72e-06	2.79e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.71e-06	2.78e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.68e-06	2.72e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.61e-06	2.61e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.58e-06	2.55e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.54e-06	2.5e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.47e-06	2.39e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.47e-06	2.39e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.41e-06	2.28e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.35e-06	2.18e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.3e-06	2.1e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.93e-07	1.28e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.78e-07	1.1e-05	CbGpPWpGaD
